News

head uk2

Chitosan and stem cells for wound healing

Stem cell therapy has received a lot of attention in recent years and has created new ways of treating the various conditions and ailments. The stem cells can differentiate into a wide variety of cell types and can positively influence inflammatory reactions. Clinical applications of stem cells are still limited, among others due to the high concentrations of ROS (reactive oxygen species) in the environment of the inflammation which limits retention of the transplanted stem cells.

Tags: wound treatment, tissue regeneration

A barrier against reactive oxygen species: chitosan/acellular dermal matrix scaffold enhances stem cell retention and improves cutaneous wound healing

Wei Lin, Xiaoyang Qi, Wenjing Guo, Danyang Liang, Heting Chen, Baoping Lin and Xiaoyuan Deng. Stem Cell Research & Therapy (2020) 11:383, https://doi.org/10.1186/s13287-020-01901-6

The authors of the study developed a novel scaffold material made of chitosan and acellular dermal matrix (ADM) as an environment for stem cells, which traps ROS and significantly weakens the inflammatory reaction. The developed scaffolds consisted of chitosan (80 % degree of deacetylation), collagenase and 2.5% glutaraldehyde. The acellular skin matrix was obtained from 5-week-old mice. The influence of the chitosan scaffold on the survival of mesenchymal stem cells and the behavior of neutrophils was investigated in vitro. In addition, the therapeutic efficiency in wound treatment was tested in a mouse model.

Results

  • Matrix with chitosan intercepts ROS in the microenvironment of the stem cells to protect them against oxidative stress
  • Attenuation of the inflammatory response triggered by neutrophils
  • Improvement of the retention of mesenchymal stem cells in the wound area over 3 weeks
  • Improved growth of blood vessels in the wound area
  • the chitosan / ADM scaffold loaded with stem cells accelerated wound closure, reduced scarring and supported wound healing in the mouse model

Conclusion: Compared to conventional matrices based on collagen, the chitosan-based system offers improved environmental conditions for the use of stem cells in wound healing.

Source: https://stemcellres.biomedcentral.com/articles/10.1186/s13287-020-01901-6

Congress and fairs

Meet us in person 2021:

  • EUCHIS, 2021
  • CPHI 2021
  • Medica 2021
  • Asia Pacific Chitin and Chitosan Symposium, 2021, South Korea

To arrange an appointment please contact Katja Richter via sales(at)medical-chitosan.com

Contact

  • Heppe Medical Chitosan GmbH
    Heinrich-Damerow-Strasse 1
    06120 Halle (Saale)
    Germany
  • Tel.: +49 (0) 345 27 996 300
    Fax: +49 (0) 345 27 996 378
  • sales@medical-chitosan.com

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.